Clinical Trial Update: Median Effective Dose of Dexmedetomidine in Elective Upper Limb Lidocaine Intravenous Regional Anesthesia [Phase 4]

View source ↗

Summary

Phase 4 trial reporting on the median effective dose of dexmedetomidine used in elective upper limb lidocaine intravenous regional anesthesia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intravenous Drug Use

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: South Valley University | Conditions: Intravenous Drug Usage | Phase 4 | Status: COMPLETED